Extend your Vision!
The totally unique optical design of the first rotationally asymmetric LENTIS Mplus has revolutionised the multifocal IOL market worldwide. Well over 350,000 Mplus implantations over 6 years and a high number of clinical trials are evidence of the superiority of this patented technology over conventional diffractive multifocal lenses. In 2013, Oculentis presented the LENTIS Mplus X, an even more advanced version of the Mplus success model that offers increased visual performance, particularly in the near range.
A new family member: LENTIS Mplus MF20
With the introduction of the lower near addition of 2 diopters, the Mplus family is now complete. The LENTIS Mplus MF20 represents the new standard in refractive lens surgery for modern vision from distance to the extended near range, without compromises. The softer transition between the two optical zones results in maximum light usage for the day-to-day intermediate range and thus leads to a brilliant vision.
LENTIS Family – Which lens for which patient?
All three Mplus options are multifocal lenses designed to correct presbyopia for optimised spectacle independence. They cover all three visual ranges (distance, intermediate and near) at varying dominances from good (**) and very good (***) to excellent (****).
Why? A patient’s everyday visual demands are more individual and different than ever before. Our everyday lives, lifestyles and professional lives determine our visual habits and every individual uses and assesses the various visual ranges differently. In addition, technical innovations in media communications further differentiate our vision: near vision is no longer simply limited to reading a newspaper or a package leaflet, but now also includes handling, reading and writing on tablets, smartphones, laptops, e-books or desktops. These everyday tasks can involve distances ranging from 25 to 75 cm and are all assigned to near or so-called intermediate vision. The LENTIS Mplus Family meets the challenge of these individually varying visual requirements. Choose the right MIOL for each of your patients and achieve the best possible patient satisfaction!
Comparative study LENTIS Mplus X and LENTIS Mplus MF30
Dr. Aloysius Joseph Low, VISTA Eye Specialist, Malaysia
Further results of the comparative study:
- Less halos and glare phenomena
- Fewer problems reading, even in low light
- Also suitable for LASIK patients, no HOA
- Easy to implant, no refractive error
- Better contrast viewing as a result of less than 5% light loss
- High patient satisfaction
Clinical results LENTIS Mplus LS-313 MF30
Prof. Dr. Jan Venter, Medical Director Optical Express, London, UK
Clinical results LENTIS Mplus LS-313 MF20
With the LS-313 MF20, Oculentis offers a Low-Add MIOL variant of LENTIS® Mplus, a lifestyle multifocal lens without side effects that focuses performance on the intermediate and far ranges. Whereas the MF30 covers the complete spectrum, the MF20 focuses on the important intermediate range while still offering good performance for reading. The best feature is that the lenses do all this without compromises, so that the 2.0 Addition (normally) gets along almost entirely without side effects such as glare, halos or double images.
Dr. Josef Reiter, Augen MVZ Landshut, GermanyDr. Robert J. Morris, Southampton University Hospitals, UK